Concepedia

Eli Lilly (Singapore)

EL

Statistics

Publications

414

Citations

91.2K

Authors

15

Location

Singapore, Singapore

Eli Lilly (Singapore) is a company institution in Singapore, Singapore known for medicine, pharmacology, and natural sciences.

HomepageROR

Top concepts

Publications

414

Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow et al. · New England Journal of Medicine · 2014 · 1.6K citations · Full text

Donanemab in Early Alzheimer’s Disease

Mark A. Mintun, Albert Lo, Cynthia Evans et al. · New England Journal of Medicine · 2021 · 1.5K citations · Full text

A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease

Rachelle S. Doody, Rema Raman, Martin R. Farlow et al. · New England Journal of Medicine · 2013 · 1.2K citations

Risk of Advanced Proximal Neoplasms in Asymptomatic Adults According to the Distal Colorectal Findings

Thomas F. Imperiale, David R. Wagner, Ching Y. Lin et al. · New England Journal of Medicine · 2000 · 1.1K citations · Full text

Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease

Lawrence S. Honig, Bruno Vellas, Merçé Boada et al. · New England Journal of Medicine · 2018 · 1K citations · Full text

1–5 of 414

Authors

15

  1. SW
    Susan Warner

    Eli Lilly (Singapore), Singapore

    14 publications · 873 citations

    11

    h-index

  2. AH
    Anne Hawdon

    Eli Lilly (Singapore), Singapore

    4 publications · 399 citations

    4

    h-index

  3. DB
    Donnelly B Kevin

    Eli Lilly (Singapore), Singapore

    3 publications · 37 citations

    3

    h-index

  4. CT
    Colleen Terrell

    Eli Lilly (Singapore), Singapore

    3 publications · 413 citations

    2

    h-index

  5. NX
    Neal X. Chen

    Eli Lilly (Singapore), Singapore

    2 publications · 158 citations

    2

    h-index

1–5 of 15